Explore
Validate
Learn
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V2197 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- MUC2 Antibody / Mucin-2
- Antibody type
- Monoclonal
- Description
- This highly specific MUC2 antibody is suitable for use in Immunohistochemistry applications with human samples.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- CCP58
- Vial size
- 20 ug (with BSA and sodium azide), 100 ug (with BSA and sodium azide), 100 ug (without BSA or sodium azide), 7 ml IHC only format (if applicable)
- Concentration
- 0.2 mg/ml, 1 mg/ml
- Storage
- Store the MUC52 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Submitted references Pathological feature and immunoprofile of cystitis glandularis accompanied with upper urinary tract obstruction.
Colloid carcinoma of the uterine cervix: a case report with respect to immunohistochemical analyses.
MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas.
Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Predictors of lymph node metastasis in T1 colorectal carcinoma: an immunophenotypic analysis of 265 patients.
Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells.
Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core.
Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types.
Second generation anti-MUC1 peptide monoclonal antibodies.
Li A, Zhou J, Lu H, Zuo X, Liu S, Zhang F, Li W, Fang W, Zhang B
BioMed research international 2014;2014:872170
BioMed research international 2014;2014:872170
Colloid carcinoma of the uterine cervix: a case report with respect to immunohistochemical analyses.
Ishida M, Iwai M, Kagotani A, Yoshida K, Okabe H
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2014 May;33(3):248-52
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2014 May;33(3):248-52
MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas.
Davison JM, Ellis ST, Foxwell TJ, Luketich JD, Gibson MK, Kuan SF, Nason KS
Human pathology 2014 Mar;45(3):540-8
Human pathology 2014 Mar;45(3):540-8
Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Tanaka M, Ushiku T, Ikemura M, Shibahara J, Seto Y, Fukayama M
Pathology international 2014 Aug;64(8):397-401
Pathology international 2014 Aug;64(8):397-401
Predictors of lymph node metastasis in T1 colorectal carcinoma: an immunophenotypic analysis of 265 patients.
Nishida T, Egashira Y, Akutagawa H, Fujii M, Uchiyama K, Shibayama Y, Hirose Y
Diseases of the colon and rectum 2014 Aug;57(8):905-15
Diseases of the colon and rectum 2014 Aug;57(8):905-15
Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells.
Ho JJ, Han SW, Pan PL, Deng G, Kuan SF, Kim YS
International journal of oncology 2003 Feb;22(2):273-9
International journal of oncology 2003 Feb;22(2):273-9
Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core.
Hanski C, Born M, Foss HD, Marowski B, Mansmann U, Arastéh K, Bachler B, Papenfuss M, Niedobitek F
The Journal of pathology 1999 Jul;188(3):304-11
The Journal of pathology 1999 Jul;188(3):304-11
Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types.
Blank M, Klussmann E, Krüger-Krasagakes S, Schmitt-Gräff A, Stolte M, Bornhoeft G, Stein H, Xing PX, McKenzie IF, Verstijnen CP
International journal of cancer 1994 Nov 1;59(3):301-6
International journal of cancer 1994 Nov 1;59(3):301-6
Second generation anti-MUC1 peptide monoclonal antibodies.
Xing PX, Prenzoska J, Quelch K, McKenzie IF
Cancer research 1992 Apr 15;52(8):2310-7
Cancer research 1992 Apr 15;52(8):2310-7
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of formalin/paraffin normal human intestine stained with MUC2 antibody (CCP58).
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of FFPE human colon carcinoma with MUC2 antibody
